Kyodo Pharmaceutical: Announcement on the Implementation of Equity Distribution in 2025
Securities code: 300966 Securities abbreviation: Gongyong Pharmaceutical Announcement number: 2026-035 Convertible bond code: 123171 Convertible bond abbreviation: Gongyong convertible bonds
Hubei Tongyong Pharmaceutical Group Co., Ltd.
Announcement on the Implementation of Equity Distribution in 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Special tips:
The 1,069,600 shares in the special securities account for repurchase by Hubei Tongyong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") will not participate in this equity distribution.
The company’s equity distribution plan for 2025: Based on the company’s total share capital of 115,281,113 shares on the date of the 13th meeting of the third board of directors, excluding the repurchased shares of 1,069,600 shares. Based on 114,211,513 shares, a cash dividend of RMB 0.45 (tax included) will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 5,139,518.09 (tax included). No bonus shares will be given, no capital reserve will be converted into share capital, and the remaining accumulated undistributed profits will be carried forward and distributed in subsequent years. If the company's share capital changes due to convertible bonds conversion or other reasons between the announcement of the profit distribution plan and before its implementation, the company will adjust the distribution ratio in accordance with the principle of "the total amount of distribution remains unchanged".
After the implementation of this equity distribution, the cash dividend (including tax) for every 10 shares converted based on the company’s total share capital (including shares held in the special securities account for repurchase) = total cash dividend/total share capital (including repurchased shares) * 10 shares = 5,139,518.09 yuan ÷ 115,281,113 shares * 10 shares = 0.445824 Yuan (retain six decimal places, the last digit is directly intercepted without rounding). The ex-rights and ex-dividend reference price after the implementation of this equity distribution = the closing price on the equity registration date – the amount of cash dividends per share converted based on the company’s total share capital = the closing price on the equity registration date – 0.0445824 yuan/share.
The company's 2025 equity distribution plan has been reviewed and approved by the company's 2025 annual shareholders' meeting held on May 19, 2026. The equity distribution matters are now announced as follows:
1. The shareholders’ meeting reviewed and approved the profit distribution plan
On May 19, 2026, the company’s 2025 annual shareholders’ meeting reviewed and approved the “Proposal on the Company’s 2025 Profit Distribution Plan”. The specific plan is as follows: Based on the company’s total share capital of 115,281,113 shares on the date of the 13th meeting of the third board of directors, excluding the repurchased shares of 1,069,600 shares, the company’s total share capital is 114,211,513 shares. Based on the number of shares, a cash dividend of RMB 0.45 (tax included) will be distributed to all shareholders for every 10 shares, with a total cash dividend of RMB 5,139,518.09 (tax included). No bonus shares will be given, no capital reserve will be converted into share capital, and the remaining accumulated undistributed profits will be carried forward for distribution in subsequent years. If the company's share capital changes due to convertible bonds conversion or other reasons between the announcement of the profit distribution plan and before its implementation, the company will adjust the distribution ratio in accordance with the principle of "the total amount of distribution remains unchanged".
From the disclosure to the implementation of this equity distribution plan, the company’s total share capital has not changed, and the base number of distributed shares has not changed.
This equity distribution plan is consistent with the "Proposal on the Company's 2025 Profit Distribution Plan" reviewed and approved by the 2025 Annual Shareholders Meeting.
The time before the distribution plan implemented this time was reviewed and approved by the shareholders’ meeting was less than two months.
2. The profit distribution plan implemented this time
Issuance year: 2025
Distribution scope: Taking the company’s total share capital of 115,281,113 shares as of the 13th meeting of the company’s third board of directors, excluding 1,069,600 repurchased shares, as the base number, a cash dividend of 0.45 yuan (tax included) will be distributed to all shareholders for every 10 shares, with a total cash dividend of 5,139,518.09 yuan distributed. Yuan (including tax; after tax, Hong Kong market investors, QFIIs, RQFIIs, and individuals and securities investment funds holding shares with pre-IPO restricted shares through Shenzhen-Hong Kong Stock Connect will be distributed 0.405 for every 10 shares Yuan; Dividend tax on individuals holding post-IPO restricted shares, equity incentive restricted shares and unrestricted tradable shares will be levied at a differentiated rate. The company will not withhold personal income tax for the time being. When the individual transfers the stock, the tax payable will be calculated based on the holding period [Note]; the dividend tax involved in securities investment funds holding post-IPO restricted shares, equity incentive restricted shares and unrestricted tradable shares will be 10% for the fund shares held by Hong Kong investors, and a differentiated tax rate will be levied on the fund shares held by mainland investors)).
[Note] Based on the first-in, first-out principle, the holding period is calculated based on the investor's securities account. If the stock is held for less than 1 month (including 1 month), the back tax is 0.09 yuan for every 10 shares; if the stock is held for more than 1 month to 1 year (including 1 year), the back tax is 0.045 yuan for every 10 shares; if the stock is held for more than 1 year, no back tax is required.
- As of the disclosure date of this announcement, the company's special securities account for repurchase holds 1,069,600 shares of the company. According to the relevant provisions of the "Company Law of the People's Republic of China" and "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 9 - Repurchase of Shares", shares in the special securities account for repurchase do not have the right to profit distribution, and the 1,069,600 shares in the company's special securities account for repurchase will not participate in this equity distribution.
3. Date of dividend payment
Equity registration date for this equity distribution: July 15, 2026
Ex-rights and ex-dividend date: July 16, 2026
4. Dividend distribution objects
The objects of this distribution are all shareholders of the company registered with China Securities Depository and Clearing Co., Ltd. Shenzhen Branch (hereinafter referred to as "China Securities Depository and Clearing Co., Ltd. Shenzhen Branch") as of the afternoon of July 15, 2026 after the Shenzhen Stock Exchange closes.
5. Equity distribution method
The cash dividends distributed by the company to A-share shareholders entrusted by China Securities Clearing Co., Ltd. Shenzhen Branch will be directly transferred to their capital accounts through the shareholders' custody securities company (or other custody institutions) on July 16, 2026.
6. Adjust related parameters
After the implementation of this equity distribution, the conversion price of the convertible corporate bonds "Co-Convertible Bonds" issued by the company will be adjusted accordingly. The conversion price of the "common convertible bonds" before the adjustment was 27.12 yuan/share, and the conversion price of the "common convertible bonds" after the adjustment was 27.08 yuan/share. The adjusted conversion price will be effective from July 16, 2026 It will take effect from the date of ex-rights and ex-dividend. For details, please refer to the "Announcement on Adjusting the Conversion Price of Common Convertible Bonds" (Announcement No.: 2026-036) disclosed by the company on the cninfo.com (www.cninfo.com.cn) on the same day.
After this equity distribution, the grant price of the company’s 2026 restricted stock incentive plan will be adjusted accordingly. The company will subsequently implement adjustment procedures and fulfill information disclosure obligations in accordance with relevant regulations.
7. Consultation methods
Consultation address: 33rd floor, Building 1, Global Financial City, Jiangshan South Road, Wolong Avenue, Fancheng District, Xiangyang City, Hubei Province Consultation contact: Wan Ying
Consultation hotline: 0710-3523126
Fax number: 0710-3523126
8. Documents for reference
Resolution of the 13th meeting of the company’s third board of directors;
Resolution of the company’s 2025 annual shareholders’ meeting;
China Securities Clearing Company Shenzhen Branch’s document confirming the specific timetable for the distribution of relevant equity.
Announcement is hereby made.
Hubei Tongyong Pharmaceutical Group Co., Ltd. Board of Directors
July 8, 2026